NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.730
+0.170 (4.78%)
At close: Jun 26, 2026, 4:00 PM EDT
3.810
+0.080 (2.14%)
After-hours: Jun 26, 2026, 7:59 PM EDT
NRx Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for NRx Pharmaceuticals stock have an average target of 40.2, with a low estimate of 25 and a high estimate of 49. The average target predicts an increase of 977.75% from the current stock price of 3.73.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NRx Pharmaceuticals stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +1,106.43% | Jun 25, 2026 |
| BTIG | BTIG | Buy Maintains $25 | Buy | Maintains | $25 | +570.24% | Jun 23, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $49 | Buy | Initiates | $49 | +1,213.67% | May 13, 2026 |
| D. Boral Capital | D. Boral Capital | Buy Maintains $34 | Buy | Maintains | $34 | +811.53% | Apr 20, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $47 → $48 | Buy | Maintains | $47 → $48 | +1,186.86% | Dec 31, 2025 |
Financial Forecast
Revenue This Year
10.19M
from 1.23M
Increased by 731.97%
Revenue Next Year
165.60M
from 10.19M
Increased by 1,524.90%
EPS This Year
-0.36
from -1.34
EPS Next Year
0.50
from -0.36
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.7M | 481.2M | |
| Avg | 10.2M | 165.6M | |
| Low | 4.3M | 6.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,671.4% | 4,621.5% | |
| Avg | 732.0% | 1,524.9% | |
| Low | 248.7% | -41.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.36 | 0.50 | |
| Avg | -0.36 | 0.50 | |
| Low | -0.36 | 0.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.